Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

See all formats and pricing
More options …
Volume 47, Issue 5


Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells

Geneviève Servais
  • Department of Immunology, CHU Brugmann Hospital (Université Libre de Bruxelles), Brussels, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rafik Karmali / Marie Paule Guillaume / Valérie Badot / Jean Duchateau
  • Department of Immunology, CHU Brugmann Hospital (Université Libre de Bruxelles), Brussels, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Francis Corazza
  • Department of Immunology, CHU Brugmann Hospital (Université Libre de Bruxelles), Brussels, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2009-03-12 | DOI: https://doi.org/10.1515/CCLM.2009.122


Background: Antinuclear autoantibody determination relies on an initial screening step using immunofluorescence on HEp2 cells. This may be followed by anti-deoxyribonucleic acid (DNA) determination, if the fluorescence of nuclei is homogeneous. We assessed the validity of a restricted algorithm and compared this to a more comprehensive algorithm that accepted any nuclear pattern as a positive indicator.

Methods: Our retrospective study analyzed routine results for antinuclear antibodies (ANA) and their anti-DNA identification [double stranded nuclear DNA (ds-DNA), membrane associated DNA (mDNA), nucleosomes] for 58 systemic lupus erythematosus (SLE) patients (690 sera). We included 158 patients with systemic or organ-specific autoimmune diseases (888 sera), 44 with viral disease (88 sera), 34 cancer patients (89 sera) and 111 patients with inflammation that served as controls (122 sera) for a total of 1187 samples.

Results: 1) Anti DNA antibodies are not associated only with a homogeneous pattern, but can also be seen with a speckled or nucleolar pattern. 2) The observed pattern is typical for a particular patient rather than for a specific pathology. 3) A homogeneous pattern does not necessarily indicate SLE, nor does the presence of circulating anti DNA antibodies. 4) Determination of various specificities of anti DNA antibodies, whatever the immunofluorescent pattern, increases the sensitivity and specificity for SLE.

Conclusions: If diagnosis is based exclusively on a homogenous pattern, preselection would have missed identification of SLE as high levels of anti DNA antibodies were also associated with speckled or nucleolar pattern.

Clin Chem Lab Med 2009;47:543–9.

Keywords: anti DNA; antinuclear antibodies; auto-antibodies; HEp2; SLE

About the article

Corresponding author: Geneviève Servais, Immunology, CHU Brugmann Université Libre de Bruxelles, Place VanGehuchten 4, 1020 Brussels, Belgium Phone: +32 2 477 25 07, Fax: +32 2 477 21 66,

Received: 2008-10-02

Accepted: 2009-01-30

Published Online: 2009-03-12

Published in Print: 2009-05-01

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 47, Issue 5, Pages 543–549, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2009.122.

Export Citation

©2009 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Nicolai Leuchten, Annika Hoyer, Ralph Brinks, Monika Schoels, Matthias Schneider, Josef Smolen, Sindhu R. Johnson, David Daikh, Thomas Dörner, Martin Aringer, and George Bertsias
Arthritis Care & Research, 2018
Jiahui Yang, Richard Pospisil, Satyajit Ray, Jacqueline Milton, Rose G. Mage, and Wasif N. Khan
PLoS ONE, 2009, Volume 4, Number 12, Page e8494
Chanwit Prapinjumrune, Chalakorn Prucktrakul, Trakarn Sooktonglarng, and Kobkan Thongprasom
Gerodontology, 2017, Volume 34, Number 1, Page 86
Renata Baronaite, Merete Engelhart, Troels Mørk Hansen, Gorm Thamsborg, Hanne Slott Jensen, Steen Stender, and Pal Bela Szecsi
Autoimmune Diseases, 2014, Volume 2014, Page 1
Nancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg, Ulrich Sack, Torsten Witte, Manfred Herold, Xavier Bossuyt, Lucille Musset, Ricard Cervera, Aresio Plaza-Lopez, Carlos Dias, Maria José Sousa, Antonella Radice, Catharina Eriksson, Olof Hultgren, Markku Viander, Munther Khamashta, Stephan Regenass, Luis Eduardo Coelho Andrade, Allan Wiik, Angela Tincani, Johan Rönnelid, Donald B Bloch, Marvin J Fritzler, Edward K L Chan, I Garcia-De La Torre, Konstantin N Konstantinov, Robert Lahita, Merlin Wilson, Olli Vainio, Nicole Fabien, Renato Alberto Sinico, Pierluigi Meroni, and Yehuda Shoenfeld
Annals of the Rheumatic Diseases, 2014, Volume 73, Number 1, Page 17
Wendy Y. Craig and Thomas B. Ledue
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 7

Comments (0)

Please log in or register to comment.
Log in